The intravenous infusion of mesenchymal stem cells from family donors is safe and improves symptoms such as pruritus (itching ...

The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...

In a first-of-its-kind clinical trial, scientists from the University of Toronto have shown that a single infusion of zimislecel — an allogeneic stem cell-derived islet therapy — can restore natural ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...

An experimental stem cell therapy could treat frailty by targeting the condition at its biological roots. Frailty – which raises the risk of falls and infections – is typically only mitigated through ...

Muscle stem cells, which are crucial for building new muscle, don’t work as well as we get older, but giving them an ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment ...